TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 8, 2013

Primary Completion Date

March 21, 2016

Study Completion Date

March 21, 2016

Conditions
Carcinoid Syndrome
Interventions
DRUG

Telotristat etiprate

Telotristat etiprate tablets.

DRUG

Placebo-matching telotristat etiprate

Placebo-matching telotristat etiprate tablets.

Trial Locations (75)

2065

Lexicon Investigational Site, Saint Leanoards

2217

Lexicon Investigational Site, Kogara

3065

Lexicon Investigational Site, Fitzroy

4029

Lexicon Investigational Site, Herston

5011

Lexicon Investigational Site, Woodville South

6160

Lexicon Investigational Site, Freemantle

9000

Lexicon Investigational Site, Ghent

10029

Lexicon Investigational Site, New York

10043

Lexicon Investigational Site, Orbassano

13353

Lexicon Investigational Site, Berlin

13385

Lexicon Investigational Site, Marseille

14263

Lexicon Investigational Site, Buffalo

19104

Lexicon Investigational Site, Philadelphia

20089

Lexicon Investigational Site, Milan

20141

Lexicon Investigational Site, Milan

20246

Lexicon Investigational Site, Hamburg

22185

Lexicon Investigational Site, Lund

23538

Lexicon Investigational Site, Lübeck

27710

Lexicon Investigational Site, Durham

28034

Lexicon Investigational Site, Madrid

28040

Lexicon Investigational Site, Madrid

32806

Lexicon Investigational Site, Orlando

35043

Lexicon Investigational Site, Marburg

36604

Lexicon Investigational Site, Mobile

40138

Lexicon Investigational Site, Bologna

40536

Lexicon Investigational Site, Lexington

41013

Lexicon Investigational Site, Seville

41126

Lexicon Investigational Site, Modena

41464

Lexicon Investigational Site, Neuss

44124

Lexicon Investigational Site, Ferrara

45147

Lexicon Investigational Site, Essen

52242

Lexicon Investigational Site, Iowa City

55131

Lexicon Investigational Site, Mainz

56124

Lexicon Investigational Site, Pisa

59037

Lexicon Investigational Site, Lille

67098

Lexicon Investigational Site, Strasbourg

68114

Lexicon Investigational Site, Omaha

69120

Lexicon Investigational Site, Heidelberg

69437

Lexicon Investigational Site, Lyon

70065

Lexicon Investigational Site, Kenner

75185

Lexicon Investigational Site, Uppsala

76104

Lexicon Investigational Site, Fort Worth

77030

Lexicon Investigational Site, Houston

78503

Lexicon Investigational Site, McAllen

80100

Lexicon Investigational Site, Napoli

81377

Lexicon Investigational Site, München

91120

Lexicon Invetigational Site, Jerusalem

92118

Lexicon Investigational Site, Clichy

94115

Lexicon Investigational Site, San Francisco

94305

Lexicon Investigational Site, Palo Alto

94805

Lexicon Investigational Site, Villejuif

99437

Lexicon Investigational Site, Bad Berka

02114

Lexicon Investigational Site, Boston

02215

Lexicon Investigational Site, Boston

B-2650

Lexicon Investigational Site, Edegem

B-5530

Lexicon Investigational Site, Yvoir

T2N 4N2

Lexicon Investigational Site, Calgary

B3H2Y9

Lexicon Investigational Site, Halifax

06156

Lexicon Investigational Site, Perugia

00189

Lexicon Investigational Site, Rome

1105 AZ

Lexicon Investigational Site, Amsterdam

5631BM

Lexicon Investigational Site, Noord-Brahant

1066CX

Lexicon Investigational Site, Noord-Holland

3015E

Lexicon Investigational Site, Zuid-Holland

08035

Lexicon Investigational Site, Barcelona

08907

Lexicon Investigational Site, Barcelona

RG249NA

Lexicon Investigational Site, Basingstoke-Hampshire

CV2 2DX

Lexicon Investigational Site, Coventry

G12OYN

Lexicon Investigational Site, Glasgow

OX37LJ

Lexicon Investigational Site, Headington-Oxford

NW32QG

Lexicon Investigational Site, London

SE59RS

Lexicon Investigational Site, London

W12 OHS

Lexicon Investigational Site, London

M204BX

Lexicon Investigational Site, Manchester

NE1 4LP

Lexicon Investigational Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY